A good year, page-9

Happy 2016 all, another prosperous year ahead. Post-SIRFLOX dose sales growth update of keen interest in Feb. HCC trial results late in the year, don't think these are factored into the SP yet and see mainly upside potential, hope to see a gradual run up leading into the result. FOXFIRE to come soon after in 2017. Maybe something on the R&D side too. Enjoy the banter and shared wisdom, much better than some of the rubbish that goes on with other stocks on HC. Cheers!